Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,899
in 3 filings, $395K under 10b5-1 plans

Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. LEONARD JOHN M −$395K President and CEO sold 3% of stake
  2. Dube Michael P −$23K VP, Chief Accounting Officer sold 3% of stake

Reading 7 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-21 DORSA CAROLINE Director Grant or award · Stock Option (right to buy) +19,000 19,000
2019-05-21 Cohen Fred E Director Grant or award · Stock Option (right to buy) +19,000 19,000
2019-03-06 SCHIERMEIER ANDREW EVP, Dev and Corp Strategy Purchase +3,250 $16.00 $52K 3,250
2019-03-06 SCHIERMEIER ANDREW EVP, Dev and Corp Strategy Purchase +4,250 $15.50 $66K 7,500
2019-03-01 Cohen Fred E Director Grant or award +10,000 $16.89 $169K 10,000
2019-01-23 Cohen Fred E Director Grant or award · Stock Option (Right to Buy) +38,000 38,000
2018-12-18 Rivera Jose E EVP, General Counsel Grant or award · Stock Option (right to buy) +71,000 71,000
2018-12-18 SCHIERMEIER ANDREW EVP, Dev and Corp Strategy Grant or award · Stock Option (right to buy) +81,000 81,000
2018-12-18 LEONARD JOHN M. President and CEO Grant or award · Stock Option (right to buy) +240,000 240,000
2018-12-18 Goddard Glenn EVP, Chief Financial Officer Grant or award · Stock Option (right to buy) +17,750 17,750
2018-11-01 Goddard Glenn See Remarks Grant or award · Stock Option (Right to Buy) +90,000 90,000
2018-11-01 Goddard Glenn SEE REMARKS Grant or award · Stock Option (Right to Buy) +90,000 90,000
2018-10-29 GOODMAN JESSE Director Grant or award · Stock Option (Right to Buy) +38,000 38,000
2018-07-16 FORMELA JEAN FRANCOIS Director Sale −5,284 $30.97 $164K 1,402
2018-07-16 FORMELA JEAN FRANCOIS Director Sale −1,402 $31.93 $45K 0
2018-06-19 FORMELA JEAN FRANCOIS Director Sale −5,286 $27.84 $147K 1,400
2018-06-19 FORMELA JEAN FRANCOIS Director Sale −1,400 $28.39 $40K 0
2018-05-17 FORMELA JEAN FRANCOIS Director Grant or award · Stock Option (right to buy) +19,000 19,000
2018-05-17 KARSEN PERRY A Director Grant or award · Stock Option (right to buy) +19,000 19,000
2018-05-17 DORSA CAROLINE Director Grant or award · Stock Option (right to buy) +19,000 19,000

Page 34 of 40 · 783 trades